KFDA Approves Extended Pediatric Application of LactiCare-HC

Published: 2005-04-11 06:56:00

Updated: 2005-04-11 06:56:00

Stiefel Korea recently announced that the Korea Food and Drug Administration (KFDA) has given an approval on the extended pediatric application of LactiCare-HC (active ingredient: hydrocortisone) Lotion for the treatment of atopic dermatitis in infants of younger than 2 years old.

According to the company, the KFDA's decision is in alignment with the current approval levels assigned to Lacti...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.